Found 436 chains in Genus chains table. Displaying 1 - 50. Applied filters: Proteins

Search results query: JmjN

Total Genus Sequence Length pdb Title
138 462 6rbiA Crystal structure of kdm5b in complex with 5-(1h-tetrazol-5-yl)quinolin-8-ol
87 318 6dq8A Linked kdm5a jmj domain bound to the inhibitor n49 i.e. 2-((2-chlorophenyl)(2-(1-methylpyrrolidin-2-yl)ethoxy)methyl)thieno[3,2-b]pyridine-7-carboxylic acid
88 316 6dq5A Linked kdm5a jmj domain bound to the inhibitor n43 i.e. 3-((6-(4-acryloyl-1,4-diazepan-1-yl)-2-(pyridin-2-yl)pyrimidin-4-yl)amino)propanoic acid
92 318 6dq4A Linked kdm5a jmj domain bound to the inhibitor gsk-j1
94 317 6dq6A Linked kdm5a jmj domain bound to the inhibitor n44 i.e. 3-((2-(pyridin-2-yl)-6-(4-(vinylsulfonyl)-1,4-diazepan-1-yl)pyrimidin-4-yl)amino)propanoic acid
87 318 6dqaA Linked kdm5a jmj domain bound to inhibitor n70 i.e.[2-((3-aminophenyl)(2-(piperidin-1-yl)ethoxy)methyl)thieno[3,2-b]pyridine-7-carboxylic acid]
87 318 6dq9A Linked kdm5a jmj domain bound to the covalent inhibitor n69 i.e. [2-((3-acrylamidophenyl)(2-(piperidin-1-yl)ethoxy)methyl)thieno[3,2-b]pyridine-7-carboxylic acid]
86 318 6dqbA Linked kdm5a jmj domain forming covalent bond to inhibitor n71 i.e. 2-((3-(4-(dimethylamino)but-2-enamido)phenyl)(2-(piperidin-1-yl)ethoxy)methyl)thieno[3,2-b]pyridine-7-carboxylic acid
98 330 6etsA Crystal structure of kdm4d with tetrazolhydrazide compound 1
103 330 6etuA Crystal structure of kdm4d with tetrazolhydrazide compound 7
105 327 6f5rA Crystal structure of kdm4d with gf028 ligand
104 330 6f5sA Crystal structure of kdm4d with tetrazole ligand gf049
97 329 6ettA Crystal structure of kdm4d with tetrazole compound 4
101 331 6etgA Crystal structure of kdm4d with tetrazolhydrazide compound 6
104 330 6etvA Crystal structure of kdm4d with tetrazolhydrazide compound 2
104 330 6eteA Crystal structure of kdm4d with tetrazolhydrazide compound 5
99 330 6etwA Crystal structure of kdm4d with tetrazolhydrazide compound 3
107 330 6f5qA Crystal structure of kdm4d with gf026 ligand
102 330 6f5tA Crystal structure of kdm4d with tetrazole ligand gf057
144 472 6ip0A Crystal structure of arabidopsis thaliana jmj13 catalytic domain in complex with akg
138 471 6ip4A Crystal structure of arabidopsis thaliana jmj13 catalytic domain in complex with nog and an h3k27me3 peptide
114 349 6g5wA Crystal structure of kdm4a with compound yp-03-038
114 351 6g5xA Crystal structure of kdm4a with compound yp-02-145
88 317 5islA Linked kdm5a jmj domain bound to the inhibitor c49 (2-{[(2-{[(e)-2-(dimethylamino)ethenyl](ethyl)amino}-2-oxoethyl)amino]methyl}pyridine-4-carboxylic acid)
142 461 5lwbA Crystal structure of human jarid1b in complex with s40650a
104 349 5ly1A Jmjd2a/ kdm4a complexed with ni(ii) and macrocyclic peptide inhibitor cp2 (13-mer)
150 462 5lw9A Crystal structure of human jarid1b in complex with s40563a
110 340 5kr7A Kdm4c bound to pyrazolo-pyrimidine scaffold
88 317 5ivvA Linked kdm5a jmj domain bound to the inhibitor n12 [3-((1-methyl-1h-pyrrolo[2,3-b]pyridin-3-yl)amino)isonicotinic acid]
91 317 5ivjA Linked kdm5a jmj domain bound to the inhibitor n11 [3-({1-[2-(4,4-difluoropiperidin-1-yl)ethyl]-5-fluoro-1h-indazol-3-yl}amino)pyridine-4-carboxylic acid]
94 317 5ivcA Linked kdm5a jmj domain bound to the inhibitor n3 (4'-[(2-phenylethyl)carbamoyl][2,2'-bipyridine]-4-carboxylic acid)
93 318 5iveA Linked kdm5a jmj domain bound to the inhibitor n8 ( 5-methyl-7-oxo-6-(propan-2-yl)-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile)
91 317 5ivfA Linked kdm5a jmj domain bound to the inhibitor n10 8-(1-methyl-1h-imidazol-4-yl)-2-(4,4,4-trifluorobutoxy)pyrido[3,4-d]pyrimidin-4-ol
90 317 5ivbA A high resolution structure of a linked kdm5a jmj domain with alpha-ketoglutarate
145 462 5fpuA Crystal structure of human jarid1b in complex with gskj1
107 345 5f3cA Crystal structure of human kdm4a in complex with compound 52d
101 346 6h8pA Jmjd2a/ kdm4a complexed with ni(ii), nog and histone h1.4(18-32)k26me3 peptide (15-mer)
141 462 6eiuA Crystal structure of kdm5b in complex with kdopz29a
140 458 6ej0A Crystal structure of kdm5b in complex with kdopz000049a.
142 462 6einA Crystal structure of kdm5b in complex with s49365a.
145 461 6eiyA Crystal structure of kdm5b in complex with kdopz000034a.
142 459 6ej1A Crystal structure of kdm5b in complex with kdopz48a.
101 350 6cg1A Crystal structure of kdm4a with compound 14
104 348 6cg2A Crystal structure of kdm4a with compound 8
85 318 6bh3A Linked kdm5a jmj domain bound to the inhibitor (s)-n-(1-(3-isopropyl-1h-pyrazole-5-carbonyl)pyrrolidin-3-yl)cyclopropanecarboxamide (compound n55)
93 318 6bgyA Linked kdm5a jmj domain bound to the inhibitor 2-((2-chlorophenyl)(2-(1-methylpyrrolidin-2-yl)ethoxy)methyl)-1h-pyrrolo[3,2-b]pyridine-7-carboxylic acid(compound 46)
88 317 6bh5A Linked kdm5a jmj domain bound to the inhibitor 2-((2-chlorophenyl)(3-(piperidin-1-yl)propoxy)methyl)-1h-pyrrolo[3,2-b]pyridine-7-carboxylic acid (compound n48)
88 318 6bgvA Linked kdm5a jmj domain bound to the inhibitor 2-((2-chlorophenyl)(2-(piperidin-1-yl)ethoxy)methyl)-1l2-pyrrolo[3,2-b]pyridine-7-carboxylic acid (compound n40)
89 317 6bgxA Linked kdm5a jmj domain bound to the inhibitor 2-((2-chlorophenyl)((4,4-difluorocyclohexyl)methoxy)methyl)-1h-pyrrolo[3,2-b]pyridine-7-carboxylic acid(compound n42)
84 318 6bh0A Linked kdm5a jmj domain bound to the inhibitor (r)-2-((2-chlorophenyl)(2-(piperidin-1-yl)ethoxy)methyl)-1l2-pyrrolo[3,2-b]pyridine-7-carboxylic acid (compound n51)